OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
April 01, 2002
Proposed funding increases for FDA reflect plans to significantly increase user fees collected from manufacturers under the Presciption Drug User Fee Act.
March 01, 2002
FDA wants manufacturers to revise product labeling and packaging and step up adverse-event monitoring to reduce risky product use.
February 01, 2002
FDA's Center for Drug Evaluation and Research is driving efforts toward creating initiatives to streamline regulatory processes, speed up drug production, and reduce costs.
January 01, 2002
Pharmaceutical companies will face a number of issues and challenges this year that will affect their resources, operations, and the markets they serve.
December 02, 2001
Anthrax contamination has put pharmaceutical quality and supply issues on the front page, along with patent and pricing policies.
November 02, 2001
Threats of bioterrorism generate new reulatory policies to protect the public against biological warfare.